Antibodies, Monoclonal, HumanizedReceptor, erbB-2Receptor, erbB-3Antibodies, MonoclonalLutetiumTaxoidsAdenocarcinoma, PapillaryBreast NeoplasmsDimerizationFallopian Tube NeoplasmsBeta ParticlesNeuregulin-1Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBridged CompoundsOvarian NeoplasmsGenes, erbB-2Intention to Treat AnalysisClinical Trials, Phase II as TopicXenograft Model Antitumor AssaysQuinazolinesDrug Administration ScheduleMolecular Targeted TherapyAntibody-Dependent Cell CytotoxicityCell Line, TumorDrug SynergismReceptor, Epidermal Growth FactorSignal TransductionVentricular Dysfunction, LeftNeoplasmsPeritoneal NeoplasmsMice, NudeMaximum Tolerated DoseNeoplasm MetastasisDisease-Free SurvivalTreatment OutcomeCarcinoma, Non-Small-Cell LungLung NeoplasmsDisease ProgressionDose-Response Relationship, DrugDeoxycytidineEpidermal Growth FactorInfusions, IntravenousDouble-Blind MethodHeartGene Expression Regulation, NeoplasticCell ProliferationTime Factors